VTAK RA MEDICAL SYSTEMS INC.

Catheter Precision, Inc. Comments on Recent Market Activity

Catheter Precision, Inc. Comments on Recent Market Activity

FORT MILL, S.C., June 12, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, is issuing this press release in response to recent increases in trading activity in its common stock. The Company is not aware of any information related to the Company or its operations that it would have expected to cause increased market activity. The Company continues to pursue its strategic plans as previously disclosed, including its ongoing efforts to secure financing to meet its liquidity needs.



CONTACTS:

At the Company

David Jenkins

973-691-2000

# # #



EN
12/06/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on RA MEDICAL SYSTEMS INC.

 PRESS RELEASE

Catheter Precision, Inc. Announces First Purchase Order From Universit...

Catheter Precision, Inc. Announces First Purchase Order From University Hospital in Rennes, France FORT MILL, S.C., July 07, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced today that it has received a purchase order from Centre Hospitalier Universitaire (CHU) de Rennes. This is the first purchase order from Universite de Rennes and marks the largest purchase order for the VIVO product line to date. serves almost 500,000 ...

 PRESS RELEASE

Catheter Precision, Inc.  Forms new Joint Venture Called Kardionav to ...

Catheter Precision, Inc.  Forms new Joint Venture Called Kardionav to Exploit patented AI Techniques to Create New VT Software platform New AI techniques to add to VT ablation tools FORT MILL, S.C., June 30, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market today announced that it has formed a joint venture, named Kardionav, to pursue the latest in technology surrounding the area of ablation for ventricular tachycardia.  The venture i...

 PRESS RELEASE

Catheter Precision, Inc. Comments on Recent Market Activity

Catheter Precision, Inc. Comments on Recent Market Activity FORT MILL, S.C., June 12, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, is issuing this press release in response to recent increases in trading activity in its common stock. The Company is not aware of any information related to the Company or its operations that it would have expected to cause increased market activity. The Company continues to pursue its strategic plans as previously disclosed, including its ongoing...

 PRESS RELEASE

Catheter Precision (VTAK) Reports Key Progress for the LockeT Product

Catheter Precision (VTAK) Reports Key Progress for the LockeT Product FORT MILL, S.C., June 12, 2025 (GLOBE NEWSWIRE) --  Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced that LockeT sales for Q2 2025 are on track to be the highest to date. Second quarter 2025 LockeT sales are already outpacing Q2 2024 sales with a 200% increase. Catheter Precision now has several US hospitals that are on track to issue more than $100,000 in purchase orders each for...

 PRESS RELEASE

Catheter Precision, Inc. Secures VIVO Purchase Order From Sahlgrenska ...

Catheter Precision, Inc. Secures VIVO Purchase Order From Sahlgrenska University Hospital SUH is the Largest Hospital in Sweden and a Highly Influential Center for VT in Scandinavia FORT MILL, S.C., June 09, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced receipt of the first purchase order for their VIVO product from Sweden. This newest purchase order comes from , the largest hospital in Sweden with 350,000 patients per...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch